Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34407342

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Aug 19
First author
Choueiri TK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2021 Aug 19;385(8):756-758. doi: 10.1056/NEJMe2109354.
    note
    Source null
    related pmid
    34407348
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2021 Oct;18(10):604. doi: 10.1038/s41571-021-00554-5.
    note
    Source null
    related pmid
    34453132
    relationship
    Comment in
  3. citation
    Eur Urol. 2022 Jan;81(1):e28. doi: 10.1016/j.eururo.2021.09.034.
    note
    Source null
    related pmid
    34742588
    relationship
    Comment in
  4. citation
    N Engl J Med. 2021 Nov 11;385(20):1919. doi: 10.1056/NEJMc2115204.
    note
    Source null
    related pmid
    34758261
    relationship
    Comment in
  5. citation
    N Engl J Med. 2021 Nov 11;385(20):1919-1920. doi: 10.1056/NEJMc2115204.
    note
    Source null
    related pmid
    34758262
    relationship
    Comment in
  6. citation
    Eur Urol. 2022 Mar;81(3):317-318. doi: 10.1016/j.eururo.2021.11.026.
    note
    Source null
    related pmid
    34895924
    relationship
    Comment in

Authors and identifiers

  1. name
    Choueiri TK
    type
    Author
  2. name
    Tomczak P
    type
    Author
  3. name
    Park SH
    type
    Author
  4. name
    Venugopal B
    type
    Author
  5. name
    Ferguson T
    type
    Author
  6. name
    Chang YH
    type
    Author
  7. name
    Hajek J
    type
    Author
  8. name
    Symeonides SN
    type
    Author
  9. name
    Lee JL
    type
    Author
  10. name
    Sarwar N
    type
    Author
  11. name
    Thiery-Vuillemin A
    type
    Author
  12. name
    Gross-Goupil M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Choueiri TK
    type
    Author
  2. name
    Tomczak P
    type
    Author
  3. name
    Park SH
    type
    Author
  4. name
    Venugopal B
    type
    Author
  5. name
    Ferguson T
    type
    Author
  6. name
    Chang YH
    type
    Author
  7. name
    Hajek J
    type
    Author
  8. name
    Symeonides SN
    type
    Author
  9. name
    Lee JL
    type
    Author
  10. name
    Sarwar N
    type
    Author
  11. name
    Thiery-Vuillemin A
    type
    Author
  12. name
    Gross-Goupil M
    type
    Author
bibliography ids
  1. nci-bib-7b9c123b492f7d20d1afb615
book metadata
content sha256
e12801ccc19404f1ba056e26e1f9245f3cfbccc74c69f87b6aa7e58e23f840a9
document type
citation
dois
  1. 10.1056/NEJMoa2106391
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34407342
immutable id
pubmed:34407342@e12801ccc19404f1ba056e26e1f9245f3cfbccc74c69f87b6aa7e58e23f840a9
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
683-694
volume
385
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2021 Aug 19;385(8):756-758. doi: 10.1056/NEJMe2109354.
    note
    Source null
    related pmid
    34407348
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2021 Oct;18(10):604. doi: 10.1038/s41571-021-00554-5.
    note
    Source null
    related pmid
    34453132
    relationship
    Comment in
  3. citation
    Eur Urol. 2022 Jan;81(1):e28. doi: 10.1016/j.eururo.2021.09.034.
    note
    Source null
    related pmid
    34742588
    relationship
    Comment in
  4. citation
    N Engl J Med. 2021 Nov 11;385(20):1919. doi: 10.1056/NEJMc2115204.
    note
    Source null
    related pmid
    34758261
    relationship
    Comment in
  5. citation
    N Engl J Med. 2021 Nov 11;385(20):1919-1920. doi: 10.1056/NEJMc2115204.
    note
    Source null
    related pmid
    34758262
    relationship
    Comment in
  6. citation
    Eur Urol. 2022 Mar;81(3):317-318. doi: 10.1016/j.eururo.2021.11.026.
    note
    Source null
    related pmid
    34895924
    relationship
    Comment in
outcomes validated
false
pmid
34407342
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
12ed721876811bb577b17fff350b0659b451077bdedb673c3456baafa794a41a
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Aug 19
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34407342/
title
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

Preserved source evidence · Not medical advice